Dexcom (NSDQ:DXCM) announced today that it signed a five-year collaboration agreement with the University of Virginia for CGM research. The partnership will focus on advancing Dexcom’s automated insulin delivery technology and exploring the use of continuous glucose monitoring (CGM) tools outside the Type 1 diabetes market, which includes inpatient hospital use, Type 2 diabetes and gestational […]
NeuroMetrix launches Quell app for Apple Watch
NeuroMetrix (NSDQ:NURO) announced that it launched the Quell Watch App for transcutaneous electrical nerve stimulation (TENS). Woburn, Mass.-based NeuroMetrix’s Quell app, which is now available for download from the Apple App Store, allows users of the Quell system to personalize and manage their therapy discreetly on iPhone and Android smartphones, according to a news release. Quell […]
Medasense raises $18M Series C
Pain-response monitoring technology developer Medasense Biometrics announced today that it raised $18 million in a Series C funding round. Ramat Gan, Israel-based Medasense collected the $18 million Series C round from Sabadell Asabys venture capital firm (Asabys Partners of Spain), Israeli family offices and returning investors Baxter Ventures, Olive Tree Ventures and LGL Capital, according […]
RapidAI raises $25M Series B
RapidAI announced today that it raised $25 million in a Series B financing round as it looks to accelerate global growth initiatives. Lennertz & Co. contributed the funds in the financing round, with its managing director Philipp Lennertz saying in a news release that RapidAI’s work has brought “measurable improvement” to patient care around the […]
Abbott launches glucose biosensor for athletes in Europe
Abbott (NYSE:ABT) announced today that it is introducing the Libre Sense glucose sport biosensor for measuring athletes’ glucose. The company touts the Libre Sense as the world’s first glucose sport biosensor, using Abbott’s FreeStyle Libre continuous glucose monitor (CGM) technology to become the first personal-use product that allows for use beyond diabetes, according to a news […]
Fitbit wins U.S., EU regulatory approval for ECG app
Fitbit (NYSE:FIT) announced today that it received FDA 510(k) and CE Mark clearance for its electrocardiogram (ECG) app. San Francisco-based Fitbit’s ECG app is designed to assess heart rhythm for atrial fibrillation (AFib), offering a simple method for on-the-spot readings, including whenever a user notices any unusual cardiac symptoms, according to a news release. The Fitbit […]
DHS warns on Philips patient monitoring systems
The U.S. Department of Homeland Security warned of several vulnerabilities in patient monitors made by Royal Philips (NYSE:PHG). Amsterdam-based Philips’ Patient Information Center iX, PerformanceBridge Focal Point, IntelliVue Patient Monitors MX100, MX400-MX850 and MP2-MP90 and IntelliVue X2 and X3 were all listed among the affected equipment in a DHS release. Potential vulnerabilities within those devices include […]
Medtronic study shows high rate of opioid-induced respiratory depression
Preliminary results from a new Medtronic (NYSE:MDT) study pinpoint a greater-than-previously measured rate of respiratory depression in patients receiving IV opioids for pain. The prospective, observational Prodigy study, which analyzed 1,335 patients across 16 sites in the U.S., Europe and Asia, found that respiratory depression, as defined by changes in pulse oximetry and capnography monitoring parameters, […]
Bardy Diagnostics names new CEO
Bardy Diagnostics announced that it appointed Kevin Hykes as its new president, CEO and member of its board effective Aug. 31, 2020. Hykes has more than 28 years of experience in the medical device industry, having served as president and CEO of Relievant Medical Systems, Metavention and Cameron Health. Additionally, Hykes held roles as an […]
FDA clears Masimo oximetry device
Masimo this week announced that its O3 Regional Oximetry received expanded FDA clearance. The expanded use covers monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin and deoxyhemoglobin in adult brains. O3 is also now indicated for use in both cerebral and somatic applications. The oximetry device uses […]
Abbott wins Medicare reimbursement for FreeStyle Libre 2
Abbott (NYSE:ABT) announced today that its next-generation FreeStyle Libre 2 iCGM is now available to Medicare patients. The integrated continuous glucose monitoring (iCGM) system met the codes for therapeutic CGM systems used for coverage by the U.S. Centers for Medicare & Medicaid Services (CMS), making it accessible to all Medicare patients with diabetes who meet the […]
- 1
- 2
- 3
- …
- 65
- Next Page »
